Temozolomide in Treating Patients With Low-Grade Glioma
Completed · Phase 2
Conditions studied: CNS Tumor, Adult
In brief
RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well temozolomide works in treating patients with supratentorial low-grade glioma.
Key facts
- Study ID
- NCT00313729
- Run by
- University of California, San Francisco
- People needed
- 120
- Starts
- 1999-05-01
- Expected to finish
- 2017-06-12
- Last updated by the study team
- 2019-02-07
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.